Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Free Cash Flow (2016 - 2021)

Historic Free Cash Flow for Neurocrine Biosciences (NBIX) over the last 12 years, with Q4 2021 value amounting to -$4.7 million.

  • Neurocrine Biosciences' Free Cash Flow fell 10522.22% to -$4.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $233.1 million, marking a year-over-year increase of 712.32%. This contributed to the annual value of $557.2 million for FY2024, which is 5409.29% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Free Cash Flow of -$4.7 million as of Q4 2021, which was down 10522.22% from $56.1 million recorded in Q3 2021.
  • Neurocrine Biosciences' Free Cash Flow's 5-year high stood at $114.2 million during Q2 2020, with a 5-year trough of -$116.4 million in Q1 2019.
  • Moreover, its 5-year median value for Free Cash Flow was $41.3 million (2017), whereas its average is $27.9 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Free Cash Flow crashed by 19337.68% in 2017, and later soared by 56688.13% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Free Cash Flow (Quarter) stood at $38.2 million in 2017, then grew by 16.48% to $44.5 million in 2018, then skyrocketed by 112.85% to $94.7 million in 2019, then decreased by 4.96% to $90.0 million in 2020, then tumbled by 105.22% to -$4.7 million in 2021.
  • Its last three reported values are -$4.7 million in Q4 2021, $56.1 million for Q3 2021, and $98.9 million during Q2 2021.